COMP <GO>
EMN vs WLK // EV/EBITDA & P/E VALUATION
Eastman Chemical Company (NYSE) VS. Westlake Corporation (NYSE) • 15-METRIC TALLY: EMN 11
— WLK 2
■ METRIC PARITY
LAST: $67.93 (+1.89%) • MKT CAP: $7.77B
valuation
10.9x
LAST: $66.01 (+0.27%) • MKT CAP: $8.44B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMN VS. WLK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMN | WLK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.10% | 7.30% | +13.80 | EMN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.80% | -11.20% | +16.00 | EMN | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 10.9x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 5.46% | -6.28% | +11.74 | EMN | /fcf-yield <GO> |
| Operating Margin | 6.60% | -14.10% | +20.70 | EMN | /operating-margins <GO> |
| Net Profit Margin | 5.40% | -13.50% | +18.90 | EMN | /net-margins <GO> |
| Revenue Growth (YoY) | -6.70% | -8.00% | +1.30 | EMN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.90% | 3.22% | +1.68 | EMN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.28 | 1.59 | +0.69 | EMN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | EMN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.3 | 52.0 | +8.30 | EMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 1.14 | -0.08 | WLK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.3x | 24.0x | -8.70 | EMN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.77B | $8.44B | -$666.2M | WLK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMN REV | WLK REV | EMN GROSS % | WLK GROSS % | EMN FCF | WLK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.75B | $11.17B | 21.1% | 7.3% | $424.0M | -$530.0M |
| FY 2024 | $9.38B | $12.14B | 24.4% | 16.1% | $688.0M | $306.0M |
| FY 2023 | $9.21B | $12.55B | — | — | $959.5M | $1.77B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMN // BETA 1.06
WLK // BETA 1.14